Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZSAN

Zosano Pharma (ZSAN) Stock Price, News & Analysis

Zosano Pharma logo

About Zosano Pharma Stock (NASDAQ:ZSAN)

Advanced Chart

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.52
$112.00
52-Week Range
$0.46
$37.45
Volume
5,685 shs
Average Volume
425,375 shs
Market Capitalization
$980.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZSAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zosano Pharma and its competitors with MarketBeat's FREE daily newsletter.

ZSAN Stock News Headlines

Aktuelle Empfehlungen zur ZOSANO
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
HOOK HOOKIPA Pharma Inc.
East Bay Business News
Astellas Pharma
Zosano Pharma Corporation (ZSANQ)
See More Headlines

ZSAN Stock Analysis - Frequently Asked Questions

Zosano Pharma Co. (NASDAQ:ZSAN) issued its quarterly earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) EPS for the quarter, missing the consensus estimate of ($1.75) by $0.01. Zosano Pharma had a negative trailing twelve-month return on equity of 177.06% and a negative net margin of 8,375.11%.

Zosano Pharma's stock reverse split before market open on Tuesday, April 12th 2022.The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Zosano Pharma (ZSAN) raised $47 million in an initial public offering (IPO) on Tuesday, January 27th 2015. The company issued 4,300,000 shares at $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zosano Pharma investors own include Tonix Pharmaceuticals (TNXP), NIO (NIO), Adamis Pharmaceuticals (ADMP), Bionano Genomics (BNGO), NightHawk Biosciences (NHWK), Sorrento Therapeutics (SRNE) and Aeterna Zentaris (AEZS).

Company Calendar

Last Earnings
5/13/2022
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZSAN
CIK
1587221
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($14.5034)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$29.92 million
Net Margins
-8,375.11%
Pretax Margin
-8,375.11%
Return on Equity
-177.06%
Return on Assets
-119.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.61
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$790 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.74 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
4,902,000
Free Float
4,784,000
Market Cap
$980.40
Optionable
Not Optionable
Beta
3.30

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ZSAN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners